Transcendent Capital Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,280
Closed -$611K 493
2024
Q2
$611K Buy
+4,280
New +$611K 0.35% 60